nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—CYP3A4—bone cancer	0.769	1	CbGaD
Ergotamine—HTR1F—trigeminal nerve—bone cancer	0.026	0.188	CbGeAlD
Ergotamine—HTR1B—dura mater—bone cancer	0.0248	0.179	CbGeAlD
Ergotamine—HTR1D—dura mater—bone cancer	0.024	0.173	CbGeAlD
Ergotamine—HTR1B—trigeminal nerve—bone cancer	0.0106	0.0769	CbGeAlD
Ergotamine—HTR1D—trigeminal nerve—bone cancer	0.0103	0.0744	CbGeAlD
Ergotamine—HTR1B—cranial nerve—bone cancer	0.00759	0.0548	CbGeAlD
Ergotamine—HTR1D—cranial nerve—bone cancer	0.00735	0.053	CbGeAlD
Ergotamine—HTR2A—trigeminal nerve—bone cancer	0.00512	0.037	CbGeAlD
Ergotamine—HTR2A—cranial nerve—bone cancer	0.00365	0.0263	CbGeAlD
Ergotamine—HTR2A—vertebral column—bone cancer	0.00358	0.0258	CbGeAlD
Ergotamine—HTR2A—hindlimb—bone cancer	0.00308	0.0222	CbGeAlD
Ergotamine—Ergoloid mesylate—CYP3A4—bone cancer	0.00287	0.26	CrCbGaD
Ergotamine—HTR2A—appendage—bone cancer	0.00264	0.019	CbGeAlD
Ergotamine—Dihydroergotamine—CYP3A4—bone cancer	0.00217	0.197	CrCbGaD
Ergotamine—Ergonovine—CYP3A4—bone cancer	0.00199	0.181	CrCbGaD
Ergotamine—Methylergometrine—CYP3A4—bone cancer	0.00174	0.158	CrCbGaD
Ergotamine—HTR1D—connective tissue—bone cancer	0.00152	0.0109	CbGeAlD
Ergotamine—Lisuride—CYP3A4—bone cancer	0.00116	0.106	CrCbGaD
Ergotamine—Bromocriptine—CYP3A4—bone cancer	0.00108	0.098	CrCbGaD
Ergotamine—HTR1B—spinal cord—bone cancer	0.00104	0.00749	CbGeAlD
Ergotamine—HTR2C—spinal cord—bone cancer	0.000995	0.00718	CbGeAlD
Ergotamine—HTR2B—tendon—bone cancer	0.000969	0.007	CbGeAlD
Ergotamine—ADRA2A—connective tissue—bone cancer	0.000886	0.00639	CbGeAlD
Ergotamine—HTR1A—spinal cord—bone cancer	0.000838	0.00605	CbGeAlD
Ergotamine—HTR2A—connective tissue—bone cancer	0.000753	0.00544	CbGeAlD
Ergotamine—ADRA2A—tendon—bone cancer	0.000609	0.00439	CbGeAlD
Ergotamine—ADRA2A—spinal cord—bone cancer	0.000587	0.00424	CbGeAlD
Ergotamine—HTR2A—tendon—bone cancer	0.000518	0.00374	CbGeAlD
Ergotamine—HTR2A—spinal cord—bone cancer	0.000499	0.0036	CbGeAlD
Ergotamine—ABCB1—bone marrow—bone cancer	0.000329	0.00237	CbGeAlD
Ergotamine—ABCB1—spinal cord—bone cancer	0.000327	0.00236	CbGeAlD
Ergotamine—HTR1E—Signaling Pathways—TGFBR2—bone cancer	5.02e-05	0.00062	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IGF1R—bone cancer	5.01e-05	0.000618	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL3—bone cancer	5e-05	0.000617	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GRM4—bone cancer	4.96e-05	0.000612	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RGS1—bone cancer	4.96e-05	0.000612	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—GNA11—bone cancer	4.87e-05	0.000601	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL3—bone cancer	4.86e-05	0.0006	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GRM1—bone cancer	4.84e-05	0.000597	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SMO—bone cancer	4.8e-05	0.000592	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	4.8e-05	0.000592	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—GNA11—bone cancer	4.79e-05	0.000591	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL3—bone cancer	4.79e-05	0.000591	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL3—bone cancer	4.78e-05	0.00059	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.77e-05	0.000589	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—SMO—bone cancer	4.76e-05	0.000588	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IGF1R—bone cancer	4.72e-05	0.000583	CbGpPWpGaD
Ergotamine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.71e-05	0.000582	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SMO—bone cancer	4.7e-05	0.00058	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	4.69e-05	0.000579	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	4.68e-05	0.000578	CbGpPWpGaD
Ergotamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.61e-05	0.000569	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GRM4—bone cancer	4.61e-05	0.000569	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RGS1—bone cancer	4.61e-05	0.000569	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.6e-05	0.000567	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—PLAU—bone cancer	4.51e-05	0.000557	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NT5C3A—bone cancer	4.47e-05	0.000552	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GRM1—bone cancer	4.46e-05	0.000551	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SMO—bone cancer	4.41e-05	0.000545	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL3—bone cancer	4.41e-05	0.000545	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GRM1—bone cancer	4.39e-05	0.000542	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—GNA11—bone cancer	4.39e-05	0.000542	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	4.36e-05	0.000538	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	4.35e-05	0.000537	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL3—bone cancer	4.34e-05	0.000536	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—GNA11—bone cancer	4.3e-05	0.000531	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GRM1—bone cancer	4.3e-05	0.000531	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL3—bone cancer	4.25e-05	0.000525	CbGpPWpGaD
Ergotamine—DRD2—Circadian rythm related genes—TP53—bone cancer	4.24e-05	0.000524	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.17e-05	0.000514	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.14e-05	0.000512	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SMO—bone cancer	4.11e-05	0.000507	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ATF1—bone cancer	4.08e-05	0.000504	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—GNA11—bone cancer	4.04e-05	0.000498	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ATF1—bone cancer	4e-05	0.000493	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GRM1—bone cancer	3.99e-05	0.000493	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL3—bone cancer	3.98e-05	0.000491	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL3—bone cancer	3.95e-05	0.000488	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL3—bone cancer	3.9e-05	0.000481	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—GNA11—bone cancer	3.76e-05	0.000464	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ATF1—bone cancer	3.75e-05	0.000463	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SMO—bone cancer	3.71e-05	0.000458	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL3—bone cancer	3.66e-05	0.000452	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—KIT—bone cancer	3.63e-05	0.000448	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SMO—bone cancer	3.58e-05	0.000442	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SMO—bone cancer	3.56e-05	0.00044	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ENO2—bone cancer	3.55e-05	0.000438	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ATF1—bone cancer	3.49e-05	0.000431	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.45e-05	0.000426	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—KIT—bone cancer	3.43e-05	0.000423	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—BRAF—bone cancer	3.41e-05	0.000421	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SMO—bone cancer	3.41e-05	0.000421	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL3—bone cancer	3.41e-05	0.00042	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFBR2—bone cancer	3.4e-05	0.00042	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—GNA11—bone cancer	3.39e-05	0.000419	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFBR2—bone cancer	3.33e-05	0.000411	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—EGFR—bone cancer	3.31e-05	0.000408	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—DHFR—bone cancer	3.29e-05	0.000406	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—GNA11—bone cancer	3.27e-05	0.000404	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.26e-05	0.000402	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—GNA11—bone cancer	3.26e-05	0.000402	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—BRAF—bone cancer	3.22e-05	0.000397	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IGF1R—bone cancer	3.2e-05	0.000395	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ATF1—bone cancer	3.15e-05	0.000389	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SMO—bone cancer	3.14e-05	0.000388	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IGF1R—bone cancer	3.14e-05	0.000387	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	3.13e-05	0.000386	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—EGFR—bone cancer	3.12e-05	0.000385	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GNA11—bone cancer	3.12e-05	0.000385	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SMO—bone cancer	3.09e-05	0.000382	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GNA11—bone cancer	3.08e-05	0.00038	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL3—bone cancer	3.07e-05	0.00038	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ATF1—bone cancer	3.04e-05	0.000376	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SMO—bone cancer	3.03e-05	0.000374	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ATF1—bone cancer	3.03e-05	0.000374	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL3—bone cancer	2.97e-05	0.000366	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL3—bone cancer	2.95e-05	0.000365	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.95e-05	0.000364	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	2.91e-05	0.00036	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.9e-05	0.000358	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GNA11—bone cancer	2.87e-05	0.000355	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MDM2—bone cancer	2.86e-05	0.000353	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.83e-05	0.000349	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL3—bone cancer	2.83e-05	0.000349	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SMO—bone cancer	2.81e-05	0.000347	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CYP3A4—bone cancer	2.79e-05	0.000344	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.77e-05	0.000342	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.74e-05	0.000338	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.74e-05	0.000338	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MDM2—bone cancer	2.7e-05	0.000333	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ATF1—bone cancer	2.67e-05	0.00033	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.63e-05	0.000325	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.63e-05	0.000325	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL3—bone cancer	2.61e-05	0.000322	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.57e-05	0.000318	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.57e-05	0.000318	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL3—bone cancer	2.56e-05	0.000317	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.54e-05	0.000313	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.53e-05	0.000312	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.51e-05	0.00031	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—JUN—bone cancer	2.49e-05	0.000307	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.47e-05	0.000305	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ENO2—bone cancer	2.45e-05	0.000303	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MMP9—bone cancer	2.42e-05	0.000299	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.42e-05	0.000298	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.39e-05	0.000295	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—bone cancer	2.39e-05	0.000295	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.39e-05	0.000295	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GSTP1—bone cancer	2.39e-05	0.000295	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.38e-05	0.000293	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—JUN—bone cancer	2.35e-05	0.000289	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.33e-05	0.000288	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—KIT—bone cancer	2.32e-05	0.000287	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MMP9—bone cancer	2.28e-05	0.000282	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—DHFR—bone cancer	2.28e-05	0.000281	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.27e-05	0.000281	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—KIT—bone cancer	2.27e-05	0.000281	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.23e-05	0.000275	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.19e-05	0.000271	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—BRAF—bone cancer	2.18e-05	0.000269	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.15e-05	0.000265	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—BRAF—bone cancer	2.14e-05	0.000264	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—KIT—bone cancer	2.14e-05	0.000264	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GNA11—bone cancer	2.13e-05	0.000263	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—EGFR—bone cancer	2.12e-05	0.000261	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IGF1R—bone cancer	2.1e-05	0.000259	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—EGFR—bone cancer	2.07e-05	0.000256	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.06e-05	0.000255	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.02e-05	0.000249	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—BRAF—bone cancer	2.01e-05	0.000248	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2e-05	0.000246	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—KIT—bone cancer	1.99e-05	0.000245	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ENO2—bone cancer	1.96e-05	0.000242	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—EGFR—bone cancer	1.95e-05	0.000241	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.95e-05	0.00024	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CYP3A4—bone cancer	1.93e-05	0.000238	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.88e-05	0.000232	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.87e-05	0.000231	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EGFR—bone cancer	1.84e-05	0.000228	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MDM2—bone cancer	1.83e-05	0.000226	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—DHFR—bone cancer	1.82e-05	0.000224	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—bone cancer	1.81e-05	0.000224	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.81e-05	0.000224	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—KIT—bone cancer	1.79e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MDM2—bone cancer	1.79e-05	0.000221	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—KIT—bone cancer	1.73e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000213	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GNA11—bone cancer	1.7e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.69e-05	0.000208	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MDM2—bone cancer	1.68e-05	0.000208	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GSTP1—bone cancer	1.65e-05	0.000204	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.65e-05	0.000204	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—bone cancer	1.64e-05	0.000203	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.63e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.63e-05	0.000201	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.0002	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—JUN—bone cancer	1.59e-05	0.000196	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.58e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000193	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—JUN—bone cancer	1.56e-05	0.000192	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.55e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—bone cancer	1.55e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—bone cancer	1.55e-05	0.000191	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.54e-05	0.00019	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.53e-05	0.000189	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KIT—bone cancer	1.52e-05	0.000188	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—bone cancer	1.51e-05	0.000187	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO2—bone cancer	1.51e-05	0.000187	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.5e-05	0.000186	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KIT—bone cancer	1.5e-05	0.000185	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.47e-05	0.000181	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—JUN—bone cancer	1.46e-05	0.000181	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—BRAF—bone cancer	1.43e-05	0.000176	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—bone cancer	1.42e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.41e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.41e-05	0.000174	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—DHFR—bone cancer	1.4e-05	0.000173	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.39e-05	0.000171	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.38e-05	0.00017	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.36e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.36e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.36e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.36e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.36e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.34e-05	0.000165	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.32e-05	0.000163	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GSTP1—bone cancer	1.32e-05	0.000163	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GNA11—bone cancer	1.31e-05	0.000162	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.3e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.28e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EGFR—bone cancer	1.25e-05	0.000154	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.24e-05	0.000153	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—bone cancer	1.24e-05	0.000153	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.23e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EGFR—bone cancer	1.22e-05	0.000151	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MDM2—bone cancer	1.2e-05	0.000148	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.2e-05	0.000148	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—JUN—bone cancer	1.19e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JUN—bone cancer	1.18e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.18e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.15e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EGFR—bone cancer	1.15e-05	0.000142	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.13e-05	0.000139	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.1e-05	0.000136	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.07e-05	0.000132	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.07e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—bone cancer	1.05e-05	0.00013	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JUN—bone cancer	1.04e-05	0.000129	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—bone cancer	1.03e-05	0.000127	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JUN—bone cancer	1.02e-05	0.000126	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GSTP1—bone cancer	1.02e-05	0.000125	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—bone cancer	1.01e-05	0.000125	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JUN—bone cancer	1e-05	0.000124	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—bone cancer	9.97e-06	0.000123	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—bone cancer	9.76e-06	0.00012	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EGFR—bone cancer	9.66e-06	0.000119	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—bone cancer	9.65e-06	0.000119	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EGFR—bone cancer	9.32e-06	0.000115	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JUN—bone cancer	9.32e-06	0.000115	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EGFR—bone cancer	9.28e-06	0.000114	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—bone cancer	9.07e-06	0.000112	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—bone cancer	8.98e-06	0.000111	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EGFR—bone cancer	8.88e-06	0.00011	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—bone cancer	8.55e-06	0.000106	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EGFR—bone cancer	8.19e-06	0.000101	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—bone cancer	8.11e-06	0.0001	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EGFR—bone cancer	8.05e-06	9.94e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EGFR—bone cancer	7.89e-06	9.74e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—bone cancer	7.83e-06	9.66e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—bone cancer	7.79e-06	9.61e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—bone cancer	7.45e-06	9.2e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EGFR—bone cancer	7.33e-06	9.05e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—bone cancer	6.87e-06	8.48e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—bone cancer	6.82e-06	8.42e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—bone cancer	6.76e-06	8.35e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—bone cancer	6.62e-06	8.17e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—bone cancer	6.15e-06	7.59e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—bone cancer	5.27e-06	6.5e-05	CbGpPWpGaD
